Nu Skin Enterprises (NUS) 10-Q2 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2022	Oct. 31, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Document Transition Report	false
Entity File Number	001-12421
Entity Registrant Name	NU SKIN ENTERPRISES, INC.
Entity Central Index Key	0001021561
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0565309
Entity Address, Address Line One	75 West Center Street
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84601
City Area Code	801
Local Phone Number	345-1000
Title of 12(b) Security	Class A Common Stock, $.001 par value
Trading Symbol	NUS
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		49,420,202

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 294,136	$ 339,593
Current investments	13,868	15,221
Accounts receivable, net	47,991	41,299
Inventories, net	327,481	399,931
Prepaid expenses and other	94,366	76,906
Total current assets	777,842	872,950
Property and equipment, net	433,367	453,674
Operating lease right-of-use assets	105,103	120,973
Goodwill	206,432	206,432
Other intangible assets, net	68,743	76,991
Other assets	171,685	175,460
Total assets	1,763,172	1,906,480
Current liabilities:
Accounts payable	41,620	49,993
Accrued expenses	281,418	372,201
Current portion of long-term debt	42,500	107,500
Total current liabilities	365,538	529,694
Operating lease liabilities	78,053	88,759
Long-term debt	382,323	268,781
Other liabilities	95,324	106,474
Total liabilities	921,238	993,708
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	609,886	601,703
Treasury stock, at cost - 40.9 million and 40.7 million shares	(1,559,967)	(1,526,860)
Accumulated other comprehensive loss	(109,385)	(73,896)
Retained earnings	1,901,309	1,911,734
Total stockholders' equity	841,934	912,772
Total liabilities and stockholders' equity	$ 1,763,172	$ 1,906,480

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares shares in Millions	Sep. 30, 2022	Dec. 31, 2021
Stockholders' equity:
Common stock, shares authorized (in shares)	500	500
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued (in shares)	90.6	90.6
Treasury stock (in shares)	40.9	40.7

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Consolidated Statements of Income [Abstract]
Revenue	$ 537,805	$ 641,152	$ 1,703,319	$ 2,022,233
Cost of sales	173,500	158,907	483,099	501,448
Gross profit	364,305	482,245	1,220,220	1,520,785
Operating expenses:
Selling expenses	216,478	260,333	678,603	816,887
General and administrative expenses	137,987	156,528	428,105	490,225
Restructuring and impairment expenses	30,124	0	30,124	0
Total operating expenses	384,589	416,861	1,136,832	1,307,112
Operating income (loss)	(20,284)	65,384	83,388	213,673
Other income (expense), net	(8,680)	2,781	(18,773)	351
Income (loss) before provision for income taxes	(28,964)	68,165	64,615	214,024
Provision (benefit) for income taxes	(3,574)	18,436	17,052	57,527
Net income (loss)	$ (25,390)	$ 49,729	$ 47,563	$ 156,497
Net income (loss) per share (Note 6):
Basic (in dollars per share)	$ (0.51)	$ 0.99	$ 0.95	$ 3.11
Diluted (in dollars per share)	$ (0.51)	$ 0.97	$ 0.94	$ 3.03
Weighted-average common shares outstanding:
Basic (in shares)	50,199	50,098	50,187	50,304
Diluted (in shares)	50,199	51,260	50,822	51,629

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Consolidated Statements of Comprehensive Income [Abstract]
Net income (loss)	$ (25,390)	$ 49,729	$ 47,563	$ 156,497
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment, net of taxes of $(10) and $(1) for the three months ended September 30, 2022 and 2021, respectively, and $19 and $1 for the nine months ended September 30, 2022 and 2021, respectively	(22,502)	(7,165)	(46,914)	(13,431)
Net unrealized gains/(losses) on cash flow hedges, net of taxes of $(1,262) and $(7) for the three months ended September 30, 2022 and 2021, respectively and $(3,441) and $(678) for the nine months ended September 30, 2022 and 2021, respectively	4,570	25	12,462	2,455
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, net of taxes of $225 and $(10) for the three months ended September 30, 2022 and 2021, respectively and $286 and $(24) for the nine months ended September 30, 2022 and 2021, respectively	(815)	35	(1,037)	86
Other comprehensive (loss) income, net of tax	(18,747)	(7,105)	(35,489)	(10,890)
Comprehensive income (loss)	$ (44,137)	$ 42,624	$ 12,074	$ 145,607

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustment, tax	$ (10)	$ (1)	$ 19	$ 1
Net unrealized gains/(losses) on foreign currency cash flow hedges, tax	(1,262)	(7)	(3,441)	(678)
Reclassification adjustment for realized losses/(gains) in current earnings on cash flow hedges, tax	$ 225	$ (10)	$ 286	$ (24)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member] Class A [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at beginning of period at Dec. 31, 2020	$ 91	$ 579,801	$ (1,461,593)	$ (64,768)	$ 1,840,740	$ 894,271
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	156,497	156,497
Other comprehensive income (loss), net of tax	0	0	0	(10,890)	0	(10,890)
Repurchase of Class A common stock (Note 6)	0	0	(70,415)	0	0	(70,415)
Exercise of employee stock options/vesting of stock awards	0	(5,599)	13,473	0	0	7,874
Stock-based compensation	0	16,476	0	0	0	16,476
Cash dividends	0	0	0	0	(57,336)	(57,336)
Balance at end of period at Sep. 30, 2021	91	590,678	(1,518,535)	(75,658)	1,939,901	936,477
Balance at beginning of period at Jun. 30, 2021	91	586,976	(1,509,867)	(68,553)	1,909,179	917,826
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	49,729	49,729
Other comprehensive income (loss), net of tax	0	0	0	(7,105)	0	(7,105)
Repurchase of Class A common stock (Note 6)	0	0	(10,005)	0	0	(10,005)
Exercise of employee stock options/vesting of stock awards	0	609	1,337	0	0	1,946
Stock-based compensation	0	3,093	0	0	0	3,093
Cash dividends	0	0	0	0	(19,007)	(19,007)
Balance at end of period at Sep. 30, 2021	91	590,678	(1,518,535)	(75,658)	1,939,901	936,477
Balance at beginning of period at Dec. 31, 2021	91	601,703	(1,526,860)	(73,896)	1,911,734	912,772
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	47,563	47,563
Other comprehensive income (loss), net of tax	0	0	0	(35,489)	0	(35,489)
Repurchase of Class A common stock (Note 6)	0	0	(60,038)	0	0	(60,038)
Exercise of employee stock options/vesting of stock awards	0	(1,137)	26,931	0	0	25,794
Stock-based compensation	0	9,320	0	0	0	9,320
Cash dividends	0	0	0	0	(57,988)	(57,988)
Balance at end of period at Sep. 30, 2022	91	609,886	(1,559,967)	(109,385)	1,901,309	841,934
Balance at beginning of period at Jun. 30, 2022	91	606,349	(1,520,769)	(90,638)	1,946,002	941,035
Stockholders' Equity [Roll Forward]
Net income (loss)	0	0	0	0	(25,390)	(25,390)
Other comprehensive income (loss), net of tax	0	0	0	(18,747)	0	(18,747)
Repurchase of Class A common stock (Note 6)	0	0	(40,028)	0	0	(40,028)
Exercise of employee stock options/vesting of stock awards	0	366	830	0	0	1,196
Stock-based compensation	0	3,171	0	0	0	3,171
Cash dividends	0	0	0	0	(19,303)	(19,303)
Balance at end of period at Sep. 30, 2022	$ 91	$ 609,886	$ (1,559,967)	$ (109,385)	$ 1,901,309	$ 841,934

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stockholders' Equity [Roll Forward]
Exercise of employee stock options (in shares)	0.1	0.1	1.2	0.6

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 47,563	$ 156,497
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	53,935	57,858
Non-cash lease expense	33,250	40,703
Stock-based compensation	9,320	16,476
Foreign currency losses	7,077	5,501
Loss on disposal of assets	568	13,210
Deferred taxes	2,483	3,846
Impairment of fixed assets and other intangibles	9,916	0
Unrealized gain on equity investments	0	(18,077)
Changes in operating assets and liabilities:
Accounts receivable, net	(15,523)	8,377
Inventories, net	48,422	(109,371)
Prepaid expenses and other	(6,801)	(29,311)
Other assets	8,030	(18,438)
Accounts payable	(1,224)	(11,182)
Accrued expenses	(95,928)	(89,993)
Other liabilities	(18,551)	5,977
Net cash provided by operating activities	82,537	32,073
Cash flows from investing activities:
Purchases of property and equipment	(45,274)	(50,384)
Proceeds on investment sales	5,535	11,171
Purchases of investments	(13,955)	(14,973)
Acquisitions, net of cash acquired	0	(18,963)
Net cash used in investing activities	(53,694)	(73,149)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	25,794	7,874
Payment of cash dividends	(57,988)	(57,336)
Repurchases of shares of common stock	(60,038)	(70,415)
Finance lease principal payments	(1,401)	(1,409)
Payment of debt issuance costs	(5,077)	0
Payments of debt	(410,000)	(77,500)
Proceeds from debt	460,000	130,000
Net cash used in financing activities	(48,710)	(68,786)
Effect of exchange rate changes on cash	(25,590)	(10,409)
Net increase (decrease) in cash and cash equivalents	(45,457)	(120,271)
Cash and cash equivalents, beginning of period	339,593	402,683
Cash and cash equivalents, end of period	$ 294,136	$ 282,412

The Company

The Company	9 Months Ended
The Company	Sep. 30, 2022
The Company [Abstract]
The Company	1. The Company Nu Skin Enterprises, Inc. (the “Company”) is a holding company, with Nu Skin, being the primary operating unit. Nu Skin develops and distributes premium-quality, innovative beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands and a small number of other products and services. The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments —Americas,

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
Summary of Significant Accounting Policies	Sep. 30, 2022
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company’s financial information as of September and for the -and nine-month periods ended September and The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form -K for the year ended December Reclassifications Certain prior period amounts have been reclassified to conform to the current presentation. The Company reclassified of events and other miscellaneous selling costs from the general and administration expenses line to the selling expenses The Company believes these costs are better reflected in selling expenses. The reclassification had no impact on operating income for the three- and nine-month periods ended September 30, Accounting Pronouncements In March 2020 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, Inventory Inventories consist of the following (U.S. dollars in thousands): September 30, 2022 December 31, 2021 Raw materials $ 141,823 $ 179,891 Finished goods 185,658 220,040 Total Inventory, net $ 327,481 $ 399,931 Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities as of September and December was and , respectively. The contract liabilities impact to revenue for the -month periods ended September and was an increase of , and 2021 was an increase of $4.3 million and a decrease of $6.3 million, respectively.

Goodwill

Goodwill	9 Months Ended
Goodwill	Sep. 30, 2022
Goodwill [Abstract]
Goodwill	3. Goodwill The Company’s reporting units for goodwill are its operating segments, which are also its reportable segments. The following table presents goodwill allocated to the Company’s reportable segments for the periods ended and December 31, 2021 (U.S. dollars in thousands): September 30, 2022 December 31, 2021 Nu Skin Americas $ 9,449 $ 9,449 Mainland China 32,179 32,179 Southeast Asia/Pacific 18,537 18,537 South Korea 29,261 29,261 Japan 16,019 16,019 EMEA 2,875 2,875 Hong Kong/Taiwan 6,634 6,634 Rhyz Investments Manufacturing 78,875 78,875 Rhyz Other 12,603 12,603 Total $ 206,432 $ 206,432

Debt

Debt	9 Months Ended
Debt	Sep. 30, 2022
Debt [Abstract]
Debt	4. Debt 2018 Credit Agreement On April 18, 2018, the Company entered into a Credit Agreement (the “2018 Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent. The 2018 Credit Agreement provided for a $400 million term loan facility and a $350 million revolving credit facility, each with a term of five years. Both facilities bore interest at the LIBOR, plus a margin based on the consolidated leverage ratio. The term loan facility amortized in quarterly installments in amounts resulting in an annual amortization of 5.0% during the first and second years, 7.5% during the third and fourth years and 10.0% during the fifth year after the closing date of the 2018 Credit Agreement, with the remainder payable at final maturity. The 2018 Credit Agreement required the Company to maintain a consolidated leverage ratio not exceeding 2.25 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. Credit Agreement On June 14, 2022, the Company entered into an Amended and Restated Credit Agreement (the “Credit Agreement”) with several financial institutions as lenders and Bank of America, N.A., as administrative agent, which amended and restated the 2018 Credit Agreement. The Credit Agreement provides for a $400 million term loan facility and a $500 million revolving credit facility, each with a term of five years. Both facilities bear interest at the SOFR, plus a margin based on the Company’s consolidated leverage ratio. Commitment fees payable under the Credit Agreement are also based on the consolidated leverage ratio as defined in the Credit Agreement and range from 0.175% to 0.30% on the unused portion of the total lender commitments then in effect. The term loan facility amortizes in quarterly installments in amounts resulting in an annual amortization of 2.5% during the first year and 5.0% during the second, third, fourth and fifth years after the closing date of the Credit Agreement, with the remainder payable at final maturity. The Credit Agreement is guaranteed by certain of the Company’s domestic subsidiaries and collateralized by assets of such subsidiaries, including a pledge of 65% of the capital stock of certain foreign subsidiaries. The Credit Agreement requires the Company to maintain a consolidated leverage ratio not exceeding 2.75 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of September 30, 2022, the Company was in compliance with all covenants under the Credit Agreement. The following table summarizes the Company’s debt facilities as of September 30, 2022 and December 31, 2021: Facility or Arrangement Original Principal Amount Balance as of September 30, 2022 (1)(2) Balance as of December 31, 2021 (1)(2) Interest Rate Repayment Terms 2018 Credit Agreement term loan facility $400.0 million — $307.5 million Variable Principal amount was paid in full during June 2022. 2018 Credit Agreement revolving credit facility — $70.0 million Variable Principal amount was paid in full during June 2022 and credit line was closed. Credit Agreement term loan facility $400.0 million $397.5 million — Variable 21% of the principal amount is payable Credit Agreement revolving credit facility $30.0 million — Variable Revolving line of credit expires June 14, 2027. (1) As of September 30, 2022 and December 31, 2021, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $12.5 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.7 million and $ million as of and December 31, 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Leases

Leases	9 Months Ended
Leases	Sep. 30, 2022
Leases [Abstract]
Leases	5. Leases As of . The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended September 30 Nine Months Ended September 30, 2022 2021 2022 2021 Operating lease expense Operating lease cost $ 9,479 $ 12,193 $ 30,179 $ 37,408 Variable lease cost 1,572 1,121 4,223 4,145 Short-term lease cost 84 13 181 590 Sublease income — (1,352 ) — (5,164 ) Finance lease expense Amortization of right-of-use assets 530 594 1,632 1,811 Interest on lease liabilities 53 77 178 248 Total lease expense $ 11,718 $ 12,646 $ 36,393 $ 39,038 Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Nine September 30 2022 2021 Operating cash outflow from operating leases $ 28,880 $ 40,072 Operating cash outflow from finance leases $ 170 $ 250 Financing cash outflow from finance leases $ 1,401 $ 1,409 Right-of-use assets obtained in exchange for operating lease obligations $ 28,785 $ 19,120 Right-of-use assets obtained in exchange for finance lease obligations $ 203 $ 59 Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31 Operating Leases Finance Leases 2022 $ 9,453 $ 505 2023 26,680 1,884 2024 19,671 1,688 2025 13,775 1,209 2026 8,127 264 Thereafter 46,139 4 Total 123,845 5,554 Less: Finance charges 16,736 319 Total principal liability $ 107,109 $ 5,235 The Company has additional lease liabilities of $ million which have not yet commenced as of September , and as such, have not been recognized on the consolidated balance sheets.

Capital Stock

Capital Stock	9 Months Ended
Capital Stock	Sep. 30, 2022
Capital Stock [Abstract]
Capital Stock	6. Capital Stock Net income per share Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the -month periods ended September 30, 2022 and stock options of 0.5 million and 0.1 million, respectively, and for the nine-month periods ended September 30, 2022 and stock options of and , respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive. Dividends In February May August 2022 October 2022 Repurchase of common stock During the three-month periods ended September 30, 2022 and 2021, the Company repurchased 1.0 million and 0.2 million shares of its Class A common stock under its stock repurchase plan for $40.0 million and $10.0 million, respectively. During the nine-month periods ended September 30, 2022 and 2021, the Company repurchased 1.4 million shares and 1.4 million shares of its Class A common stock under its stock repurchase plan for $60.0 million and $70.4 million, respectively. As of September 30, 2022,

Fair Value and Equity Investmen

Fair Value and Equity Investments	9 Months Ended
Fair Value and Equity Investments	Sep. 30, 2022
Fair Value and Equity Investments [Abstract]
Fair Value and Equity Investments	7. Fair Value and Equity Investments Fair Value The carrying value of financial instruments including cash and cash equivalents, accounts receivable and accounts payable approximates fair values due to the short-term nature of these instruments. The carrying value of debt approximates fair value due to the variable 30-day interest rate. Fair value estimates are made at a specific point in time, based on relevant market information. The FASB Codification defines fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. On a quarterly basis, the Company measures at fair value certain financial assets, including cash equivalents. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair-value hierarchy: ■ Level 1 – quoted prices in active markets for identical assets or liabilities; ■ Level 2 – inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and ■ Level 3 – unobservable inputs based on the Company’s own assumptions. Accounting standards permit companies, at their option, to measure certain financial instruments and other eligible items at fair value. The Company has elected not to apply the fair value option to existing eligible items beyond what is required by US GAAP. The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2022 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 68,552 $ — $ — $ 68,552 Derivative financial instruments asset — 21,168 — 21,168 Life insurance contracts — — 38,302 38,302 Contingent consideration — — (8,372 ) (8,372 ) Total $ 68,552 $ 21,168 $ 29,930 $ 119,650 Fair Value at December 31, 2021 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 66,477 $ — $ — $ 66,477 Derivative financial instruments asset — 6,590 — 6,590 Life insurance contracts — — 49,851 49,851 Contingent consideration — — (10,341 ) (10,341 ) Total $ 66,477 $ 6,590 $ 39,510 $ 112,577 The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands): 2022 2021 Beginning balance at January 1 $ 49,851 $ 45,453 Actual return on plan assets (11,549 ) 3,172 Purchases and issuances — 7,016 Sales and settlements — (7,016 ) Transfers into Level 3 — — Ending balance at September 30 $ 38,302 $ 48,625 Life insurance contracts: The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands): 2022 2021 Beginning balance at January 1 $ (10,341 ) $ (3,125 ) Additions from acquisitions — (8,702 ) Changes in fair value of contingent consideration 1,969 (305 ) Ending balance at September 30 $ (8,372 ) $ (12,132 ) Contingent consideration: Equity Investments The Company maintains equity investments in companies which are accounted for under the measurement alternative described in ASC - - - for equity securities that lack readily determinable fair values. The carrying amount of equity securities held by the Company without readily determinable fair values was at each of September and December During the months ended September the Company recognized upward fair value adjustments, based on the valuation of additional equity issued by the investee which was deemed to be an observable transaction of a similar investment under ASC was recorded within Other income (expense), net on the Consolidated Statement of Income. The upward fair value adjustment represents a nonrecurring fair value measurement based on observable price changes and is classified as a Level fair value measurement.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2022
Income Taxes [Abstract]
Income Taxes	8. Income Taxes Provision for income taxes for the three- and nine-month periods ended September 30, 2022 was $(3.6) million and $17.1 million, compared to $18.4 million and $57.5 million for the prior-year periods. The effective tax rates for the three- and nine-month periods ended September 30, 2022, were 12.3% and 26.4% of pre-tax income compared to 27.0% and 26.9% in the prior-year periods. The Company accounts for income taxes in accordance with ASC Topic 740 “Income Taxes.” These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise’s activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. The Company had net deferred tax assets of $22.2 million and $24.1 million as of September 30, 2022 and December 31, 2021, respectively. The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. For all foreign earnings, the Company accrues the applicable foreign income taxes. For the earnings that have been indefinitely reinvested, the Company does not accrue foreign withholding taxes. Undistributed earnings that the Company has indefinitely reinvested, for which no foreign withholding taxes have been provided, aggregate to $60.0 million as of December 31, 2021. If the amount designated as indefinitely reinvested as of December 31, 2021 was repatriated to the United States, the amount of incremental taxes would be approximately $6.0 million. The Company intends to utilize the indefinitely reinvested offshore earnings to fund foreign investments, specifically capital expenditures. The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process (“CAP”). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. As of December 31, 2021, tax years through 2020 have been audited and are effectively closed to further examination. For tax years 2021 and 2022, the Company is in the Bridge phase of the CAP program, pursuant to which the IRS will not accept disclosures, will not conduct reviews and will not provide letters of assurance for the Bridge years. There are limited circumstances under which tax years in the Bridge phase will be opened for examination. The Company may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2018. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2016. However, statutes of limitations in certain countries may be as long as ten years. The Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable. The Company’s unrecognized tax benefits relate to multiple jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitations, it is reasonably possible that the Company’s gross unrecognized tax benefits, net of foreign currency adjustments, may increase in the next 12 months by approximately $1.0 to $2.0 million.

Derivatives and Hedging Activit

Derivatives and Hedging Activities	9 Months Ended
Derivatives and Hedging Activities	Sep. 30, 2022
Derivatives and Hedging Activities [Abstract]
Derivatives and Hedging Activities	9. Derivatives and Hedging Activities Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. During 2022, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated and that qualify as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income and subsequently reclassified into interest expense/income in the same period(s) during which the hedged transaction affects earnings. Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense/income as interest payments are made/received on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $8.2 million will be reclassified as a reduction to interest expense. As of September 30, 2022 and December 31, 2021, the Company had four outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk with a total notional amount of $200 million. Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments Derivatives in Cash flow Hedging Relationships: Balance Sheet Location September 30, 2022 December 31, 2021 Interest Rate Swap - Asset Prepaid expenses and other $ 8,178 $ 557 Interest Rate Swap - Asset Other assets $ 12,990 $ 6,033 Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income. Amount of Gain (Loss) Recognized in OCI on Derivatives Three Months Ended Nine Months Ended Derivatives in Cash flow September 30, September 30, Hedging Relationships: 2022 2021 2022 2021 Interest Rate Swaps $ 5,832 $ 32 $ 15,903 $ 3,133 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Nine Months Ended Derivatives in Cash flow Income Statement September 30, September 30, Hedging Relationships: Location 2022 2021 2022 2021 Interest Rate Swaps Other income (expense), net $ 1,040 $ (45 ) $ 1,323 $ (110 )

Segment Information

Segment Information	9 Months Ended
Segment Information	Sep. 30, 2022
Segment Information [Abstract]
Segment Information	10. Segment Information The Company reports revenue from nine segments, consisting of its seven geographic Nu Skin segments—Americas, Mainland China, Southeast Asia/Pacific, South Korea, Japan, EMEA, and Hong Kong/Taiwan—and two Rhyz Investments segments—Manufacturing and Rhyz other. The Nu Skin other category includes miscellaneous corporate revenue and related adjustments. The Rhyz other segment includes other investments by our Rhyz strategic investment arm. These segments reflect the way the chief operating decision maker evaluates the Company’s business performance and allocates resources. Reported revenue includes only the revenue generated by sales to external customers. Profitability by segment as determined under US GAAP is driven primarily by the Company’s transfer pricing policies. Segment contribution, which is the Company’s segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company’s executive and administrative offices, information technology, research and development, and marketing and supply chain functions not recorded at the segment level. Prior year segment information has been recast to reflect the move of the Pacific components from the “America/Pacific” operating segment to the “Southeast Asia/Pacific” operating segment to comply with current segment presentation. Prior year segment information has been recast to reflect the fourth quarter 2021 exit of the Grow Tech segment, which has been recast to Corporate and other expenses. Consolidated financial information is not affected. The accounting policies of the segments are the same as those described in Note 2 – Summary of Significant Accounting Policies. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations. Summarized financial information for the Company’s reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company’s internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment. Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 131,591 $ 131,482 $ 379,616 $ 403,755 Mainland China 75,151 134,291 286,454 438,066 Southeast Asia/Pacific 83,502 79,081 267,805 246,338 South Korea 67,237 91,989 208,678 261,724 Japan 53,276 65,117 171,019 203,001 EMEA 45,099 55,839 148,938 215,134 Hong Kong/Taiwan 39,587 39,921 117,408 114,795 Nu Skin other 496 1,672 2,434 3,497 Total Nu Skin 495,939 599,392 1,582,352 1,886,310 Rhyz Investments Manufacturing (1) 41,328 41,635 119,898 135,760 Rhyz other 538 125 1,069 163 Total Rhyz Investments 41,866 41,760 120,967 135,923 Total $ 537,805 $ 641,152 $ 1,703,319 $ 2,022,233 (1) The Manufacturing segment had $17.5 million and $27.4 million of intersegment revenue for the three months ended September Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 23,016 $ 25,752 $ 78,165 $ 83,495 Mainland China 12,933 30,677 54,873 121,596 Southeast Asia/Pacific 20,719 19,020 68,492 59,881 South Korea 20,455 28,984 63,776 84,401 Japan 13,103 16,267 41,867 50,709 EMEA 3,379 6,693 13,377 29,270 Hong Kong/Taiwan 8,425 8,940 26,276 24,848 Nu Skin contribution 102,030 136,333 346,826 454,200 Rhyz Investments Manufacturing 1,755 3,059 6,235 15,649 Rhyz other (1,724 ) (659 ) (4,069 ) (1,178 ) Rhyz Investments contribution 31 2,400 2,166 14,471 Total segment contribution 102,061 138,733 348,992 468,671 Corporate and other (122,345 ) (73,349 ) (265,604 ) (254,998 ) Operating income (20,284 ) 65,384 83,388 213,673 Other income (expense) (8,680 ) 2,781 (18,773 ) 351 Income before provision for income taxes $ (28,964 ) $ 68,165 $ 64,615 $ 214,024 Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 89 $ 190 $ 480 $ 656 Mainland China 3,528 3,253 9,088 9,868 Southeast Asia/Pacific 382 359 1,144 1,096 South Korea 377 805 1,137 2,768 Japan 148 220 670 699 EMEA 125 281 599 850 Hong Kong/Taiwan 743 1,004 2,152 2,794 Total Nu Skin 5,392 6,112 15,270 18,731 Rhyz Investments Manufacturing 3,161 3,069 9,773 8,644 Rhyz other 592 592 1,776 987 Total Rhyz Investments 3,753 3,661 11,549 9,631 Corporate and other 9,025 10,160 27,116 29,496 Total $ 18,170 $ 19,933 $ 53,935 $ 57,858 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 23 $ 95 $ 152 $ 294 Mainland China 2,946 3,237 9,066 15,170 Southeast Asia/Pacific 19 92 143 1,015 South Korea 35 — 613 508 Japan 16 3 200 94 EMEA 183 391 961 821 Hong Kong/Taiwan 587 110 1,386 222 Total Nu Skin 3,809 3,928 12,521 18,124 Rhyz Investments Manufacturing 1,923 2,604 4,353 11,604 Rhyz other — — — — Total Rhyz Investments 1,923 2,604 4,353 11,604 Corporate and other 19,723 7,003 28,400 20,656 Total $ 25,455 $ 13,535 $ 45,274 $ 50,384

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2022
Commitments and Contingencies [Abstract]
Commitments and Contingencies	11. Commitments and Contingencies The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company’s direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company’s sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company’s operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. No assurance can be given that the Company’s compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company’s financial position, results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation, investigations and other proceedings involving various matters. Management believes that the ultimate liability arising from such claims and contingencies, if any, is not likely to have a material adverse effect on the Company’s consolidated financial condition, results of operations or cash flows. The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company’s reserves, which would impact its reported financial results.

Acquisitions

Acquisitions	9 Months Ended
Acquisitions	Sep. 30, 2022
Acquisitions [Abstract]
Acquisitions	12. Acquisitions In April 2021, the Company acquired 100% ownership in MyFavoriteThings, Inc. (“Mavely”), making Mavely a wholly owned subsidiary of the Company. The acquisition enables the Company to continue to expand its digital tools. The purchase price for Mavely was $16.8 million, net of cash acquired of $0.4 million and $0.9 million to be paid within six months, all payable in cash. In addition, there is potential for an incremental $24.0 million in contingent consideration, which becomes payable if certain revenue and profitability targets are reached in 2021, 2022 and 2023. The fair value of the contingent consideration recorded on the acquisition date was $8.7 million. The Company allocated the gross purchase price of $29.4 million to the assets acquired and liabilities assumed at estimated fair values. The estimated fair value of assets acquired included $16.4 million of intangible assets, $0.4 million of cash, $0.1 million of accounts receivable, and also resulted in a deferred tax liability of $3.5 million. The excess purchase price over the aggregate fair value of assets acquired less liabilities assumed of $12.6 million was recorded as goodwill. The goodwill recognized is attributable primarily to expected synergies. None of the goodwill is expected to be deductible for income tax purposes. The intangible assets acquired were comprised of $2.0 million for customer relationships, $11.3 million for technology, $2.8 million for trademarks and $0.3 million for other intangibles. The intangibles were assigned useful lives of 8 years for the technology and tradename, approximately 4 years for the customer relationships and 3 years for the other intangibles. All the goodwill was assigned to our Rhyz other segment. The allocation of the fair value of assets acquired and liabilities assumed for the acquisition was finalized during the three months ended September 30, 2021.

Restructuring

Restructuring	9 Months Ended
Restructuring	Sep. 30, 2022
Restructuring [Abstract]
Restructuring	13. Restructuring In the fourth quarter of 2021, the Company determined to exit the Grow Tech segment, to better align its resources on key strategic initiatives to achieve the future growth objectives and priorities of the core Nu Skin business. The Grow Tech segment was pursuing the commercialization of controlled-environment agriculture for use in the agriculture feed industry. This segment had been operating as part of the Company’s Rhyz strategic investment arm. As a result of the restructuring program, the Company recorded a non-cash charge of $38.5 million in 2021, including $9.2 million for impairment of goodwill, $9.0 million for impairment of intangibles, $13.7 million of fixed asset impairments and $6.6 million for inventory write-off, and $20.0 million of cash charges, including $6.5 million for employee severance and $13.5 million for other related cash charges with our restructuring. As of December 31, 2021, the $20.0 million liability related to cash charges was recorded within Accrued expenses. During the first quarter of 2022, the Company made cash payments of $11.6 million, leaving an ending restructuring accrual of $8.3 million as of March 31, 2022. During the second quarter of 2022, the Company made cash payments of $8.0 million, leaving an ending restructuring accrual of $0.3 million as of June 30, 2022. During the third quarter of 2022, the Company made cash payments of $0.3 million, leaving no restructuring accrual as of September 30, 2022. The restructuring charges were recorded in the previous Grow Tech segment, which in the current year has been recast to Corporate and Other. In the third quarter of 2022, the Company adopted a strategic plan to focus resources on the Company’s strategic priorities and optimize future growth and profitability. The global program includes workforce reductions and footprint optimization. The Company estimates total charges under the program will approximate $35–$45 million, with $30–$35 million in cash charges of severance and lease termination cost and $9.9 million of non-cash charges of impairment of fixed assets and other intangibles related to the footprint optimization. The Company expects to substantially complete the program during the first half of 2023. During the third quarter of 2022, the Company incurred charges to be settled in cash of $17.2 million in severance charges, $2.1 million in lease termination cost, and $0.9 million in other associated cost, and non-cash charges of $8.2 million in fixed asset impairments and $1.7 million in impairment of other intangibles. During the third quarter of 2022, the Company made cash payments of $7.9 million related to this global program, leaving an ending restructuring accrual of $12.3 million. Restructuring expense by segment (U.S. dollars in thousands) Three Months Ended September 30,2022 Nu Skin Americas $ 1,723 Mainland China 11,484 Southeast Asia/Pacific 663 South Korea 54 Japan — EMEA 894 Hong Kong/Taiwan 747 Total Nu Skin 15,565 Rhyz Investments Manufacturing — Rhyz other — Total Rhyz Investments — Corporate and other 14,559 Total $ 30,124

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2022
Summary of Significant Accounting Policies [Abstract]
Basis of Accounting	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”)
Consolidation	The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.
Reclassifications	Reclassifications Certain prior period amounts have been reclassified to conform to the current presentation. The Company reclassified of events and other miscellaneous selling costs from the general and administration expenses line to the selling expenses The Company believes these costs are better reflected in selling expenses. The reclassification had no impact on operating income for the three- and nine-month periods ended September 30,
Accounting Pronouncements	Accounting Pronouncements In March 2020 Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,
Inventory	Inventory Inventories consist of the following (U.S. dollars in thousands): September 30, 2022 December 31, 2021 Raw materials $ 141,823 $ 179,891 Finished goods 185,658 220,040 Total Inventory, net $ 327,481 $ 399,931
Revenue Recognition	Revenue Recognition Contract Liabilities – Customer Loyalty Programs Contract liabilities, recorded as deferred revenue within the accrued expenses line in the consolidated balance sheets, include loyalty point program deferrals with certain customers which are accounted for as a reduction in the transaction price and are generally recognized as points are redeemed for additional products. The balance of deferred revenue related to contract liabilities as of September and December was and , respectively. The contract liabilities impact to revenue for the -month periods ended September and was an increase of , and 2021 was an increase of $4.3 million and a decrease of $6.3 million, respectively.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
Summary of Significant Accounting Policies (Tables)	Sep. 30, 2022
Summary of Significant Accounting Policies [Abstract]
Inventories	Inventories consist of the following (U.S. dollars in thousands): September 30, 2022 December 31, 2021 Raw materials $ 141,823 $ 179,891 Finished goods 185,658 220,040 Total Inventory, net $ 327,481 $ 399,931

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
Goodwill (Tables)	Sep. 30, 2022
Goodwill [Abstract]
Goodwill	The following table presents goodwill allocated to the Company’s reportable segments for the periods ended and December 31, 2021 (U.S. dollars in thousands): September 30, 2022 December 31, 2021 Nu Skin Americas $ 9,449 $ 9,449 Mainland China 32,179 32,179 Southeast Asia/Pacific 18,537 18,537 South Korea 29,261 29,261 Japan 16,019 16,019 EMEA 2,875 2,875 Hong Kong/Taiwan 6,634 6,634 Rhyz Investments Manufacturing 78,875 78,875 Rhyz Other 12,603 12,603 Total $ 206,432 $ 206,432

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Sep. 30, 2022
Debt [Abstract]
Debt Facilities	The following table summarizes the Company’s debt facilities as of September 30, 2022 and December 31, 2021: Facility or Arrangement Original Principal Amount Balance as of September 30, 2022 (1)(2) Balance as of December 31, 2021 (1)(2) Interest Rate Repayment Terms 2018 Credit Agreement term loan facility $400.0 million — $307.5 million Variable Principal amount was paid in full during June 2022. 2018 Credit Agreement revolving credit facility — $70.0 million Variable Principal amount was paid in full during June 2022 and credit line was closed. Credit Agreement term loan facility $400.0 million $397.5 million — Variable 21% of the principal amount is payable Credit Agreement revolving credit facility $30.0 million — Variable Revolving line of credit expires June 14, 2027. (1) As of September 30, 2022 and December 31, 2021, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $12.5 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement. (2) The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.7 million and $ million as of and December 31, 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Sep. 30, 2022
Leases [Abstract]
Components of Lease Expense	The components of lease expense were as follows (U.S. dollars in thousands): Three Months Ended September 30 Nine Months Ended September 30, 2022 2021 2022 2021 Operating lease expense Operating lease cost $ 9,479 $ 12,193 $ 30,179 $ 37,408 Variable lease cost 1,572 1,121 4,223 4,145 Short-term lease cost 84 13 181 590 Sublease income — (1,352 ) — (5,164 ) Finance lease expense Amortization of right-of-use assets 530 594 1,632 1,811 Interest on lease liabilities 53 77 178 248 Total lease expense $ 11,718 $ 12,646 $ 36,393 $ 39,038
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows (U.S. dollars in thousands): Nine September 30 2022 2021 Operating cash outflow from operating leases $ 28,880 $ 40,072 Operating cash outflow from finance leases $ 170 $ 250 Financing cash outflow from finance leases $ 1,401 $ 1,409 Right-of-use assets obtained in exchange for operating lease obligations $ 28,785 $ 19,120 Right-of-use assets obtained in exchange for finance lease obligations $ 203 $ 59
Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (U.S. dollars in thousands): Year Ending December 31 Operating Leases Finance Leases 2022 $ 9,453 $ 505 2023 26,680 1,884 2024 19,671 1,688 2025 13,775 1,209 2026 8,127 264 Thereafter 46,139 4 Total 123,845 5,554 Less: Finance charges 16,736 319 Total principal liability $ 107,109 $ 5,235

Fair Value and Equity Investm_2

Fair Value and Equity Investments (Tables)	9 Months Ended
Fair Value and Equity Investments (Tables)	Sep. 30, 2022
Fair Value and Equity Investments [Abstract]
Assets (Liabilities) Measured at Fair Value on a Recurring Basis	The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands): Fair Value at September 30, 2022 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 68,552 $ — $ — $ 68,552 Derivative financial instruments asset — 21,168 — 21,168 Life insurance contracts — — 38,302 38,302 Contingent consideration — — (8,372 ) (8,372 ) Total $ 68,552 $ 21,168 $ 29,930 $ 119,650 Fair Value at December 31, 2021 Level 1 Level 2 Level 3 Total Financial assets (liabilities): Cash equivalents and current investments $ 66,477 $ — $ — $ 66,477 Derivative financial instruments asset — 6,590 — 6,590 Life insurance contracts — — 49,851 49,851 Contingent consideration — — (10,341 ) (10,341 ) Total $ 66,477 $ 6,590 $ 39,510 $ 112,577
Changes in Fair Value of Level 3 Life Insurance Contracts	The following table provides a summary of changes in fair value of the Company’s Level 3 life insurance contracts (U.S. dollars in thousands): 2022 2021 Beginning balance at January 1 $ 49,851 $ 45,453 Actual return on plan assets (11,549 ) 3,172 Purchases and issuances — 7,016 Sales and settlements — (7,016 ) Transfers into Level 3 — — Ending balance at September 30 $ 38,302 $ 48,625
Changes in Fair Value of Level 3 Contingent Consideration	The following table provides a summary of changes in fair value of the Company’s Level 3 contingent consideration (U.S. dollars in thousands): 2022 2021 Beginning balance at January 1 $ (10,341 ) $ (3,125 ) Additions from acquisitions — (8,702 ) Changes in fair value of contingent consideration 1,969 (305 ) Ending balance at September 30 $ (8,372 ) $ (12,132 )

Derivatives and Hedging Activ_2

Derivatives and Hedging Activities (Tables)	9 Months Ended
Derivatives and Hedging Activities (Tables)	Sep. 30, 2022
Derivatives and Hedging Activities [Abstract]
Fair Values of Derivative Instruments on the Balance Sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Balance Sheet: Fair Values of Derivative Instruments Derivatives in Cash flow Hedging Relationships: Balance Sheet Location September 30, 2022 December 31, 2021 Interest Rate Swap - Asset Prepaid expenses and other $ 8,178 $ 557 Interest Rate Swap - Asset Other assets $ 12,990 $ 6,033
Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income	The tables below present the effect of cash flow hedge accounting on Accumulated Other Comprehensive Income. Amount of Gain (Loss) Recognized in OCI on Derivatives Three Months Ended Nine Months Ended Derivatives in Cash flow September 30, September 30, Hedging Relationships: 2022 2021 2022 2021 Interest Rate Swaps $ 5,832 $ 32 $ 15,903 $ 3,133 Amount of Gain (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income Three Months Ended Nine Months Ended Derivatives in Cash flow Income Statement September 30, September 30, Hedging Relationships: Location 2022 2021 2022 2021 Interest Rate Swaps Other income (expense), net $ 1,040 $ (45 ) $ 1,323 $ (110 )

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
Segment Information (Tables)	Sep. 30, 2022
Segment Information [Abstract]
Revenue by Segment	Revenue by Segment Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 131,591 $ 131,482 $ 379,616 $ 403,755 Mainland China 75,151 134,291 286,454 438,066 Southeast Asia/Pacific 83,502 79,081 267,805 246,338 South Korea 67,237 91,989 208,678 261,724 Japan 53,276 65,117 171,019 203,001 EMEA 45,099 55,839 148,938 215,134 Hong Kong/Taiwan 39,587 39,921 117,408 114,795 Nu Skin other 496 1,672 2,434 3,497 Total Nu Skin 495,939 599,392 1,582,352 1,886,310 Rhyz Investments Manufacturing (1) 41,328 41,635 119,898 135,760 Rhyz other 538 125 1,069 163 Total Rhyz Investments 41,866 41,760 120,967 135,923 Total $ 537,805 $ 641,152 $ 1,703,319 $ 2,022,233 (1) The Manufacturing segment had $17.5 million and $27.4 million of intersegment revenue for the three months ended September
Segment Contribution	Segment Contribution Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 23,016 $ 25,752 $ 78,165 $ 83,495 Mainland China 12,933 30,677 54,873 121,596 Southeast Asia/Pacific 20,719 19,020 68,492 59,881 South Korea 20,455 28,984 63,776 84,401 Japan 13,103 16,267 41,867 50,709 EMEA 3,379 6,693 13,377 29,270 Hong Kong/Taiwan 8,425 8,940 26,276 24,848 Nu Skin contribution 102,030 136,333 346,826 454,200 Rhyz Investments Manufacturing 1,755 3,059 6,235 15,649 Rhyz other (1,724 ) (659 ) (4,069 ) (1,178 ) Rhyz Investments contribution 31 2,400 2,166 14,471 Total segment contribution 102,061 138,733 348,992 468,671 Corporate and other (122,345 ) (73,349 ) (265,604 ) (254,998 ) Operating income (20,284 ) 65,384 83,388 213,673 Other income (expense) (8,680 ) 2,781 (18,773 ) 351 Income before provision for income taxes $ (28,964 ) $ 68,165 $ 64,615 $ 214,024
Depreciation and Amortization and Capital Expenditures	Depreciation and Amortization Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 89 $ 190 $ 480 $ 656 Mainland China 3,528 3,253 9,088 9,868 Southeast Asia/Pacific 382 359 1,144 1,096 South Korea 377 805 1,137 2,768 Japan 148 220 670 699 EMEA 125 281 599 850 Hong Kong/Taiwan 743 1,004 2,152 2,794 Total Nu Skin 5,392 6,112 15,270 18,731 Rhyz Investments Manufacturing 3,161 3,069 9,773 8,644 Rhyz other 592 592 1,776 987 Total Rhyz Investments 3,753 3,661 11,549 9,631 Corporate and other 9,025 10,160 27,116 29,496 Total $ 18,170 $ 19,933 $ 53,935 $ 57,858 Capital Expenditures Three Months Ended September 30, Nine Months Ended September 30, (U.S. dollars in thousands) 2022 2021 2022 2021 Nu Skin Americas $ 23 $ 95 $ 152 $ 294 Mainland China 2,946 3,237 9,066 15,170 Southeast Asia/Pacific 19 92 143 1,015 South Korea 35 — 613 508 Japan 16 3 200 94 EMEA 183 391 961 821 Hong Kong/Taiwan 587 110 1,386 222 Total Nu Skin 3,809 3,928 12,521 18,124 Rhyz Investments Manufacturing 1,923 2,604 4,353 11,604 Rhyz other — — — — Total Rhyz Investments 1,923 2,604 4,353 11,604 Corporate and other 19,723 7,003 28,400 20,656 Total $ 25,455 $ 13,535 $ 45,274 $ 50,384

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
Restructuring (Tables)	Sep. 30, 2022
Restructuring [Abstract]
Restructuring Expense by Segment	Restructuring expense by segment (U.S. dollars in thousands) Three Months Ended September 30,2022 Nu Skin Americas $ 1,723 Mainland China 11,484 Southeast Asia/Pacific 663 South Korea 54 Japan — EMEA 894 Hong Kong/Taiwan 747 Total Nu Skin 15,565 Rhyz Investments Manufacturing — Rhyz other — Total Rhyz Investments — Corporate and other 14,559 Total $ 30,124

The Company (Details)

The Company (Details)	9 Months Ended
The Company (Details)	Sep. 30, 2022 Segment
The Company [Abstract]
Number of reportable segments	9
Number of geographic segments	7
Number of Rhyz Investments segments	2

Summary of Significant Accoun_4

Summary of Significant Accounting Policies, Reclassifications (Details) - Reclassification Adjustment [Member] - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
General and Administration Expenses [Member]
Reclassifications [Abstract]
Events and other miscellaneous selling costs	$ (4.6)	$ (9.5)
Selling Expenses [Member]
Reclassifications [Abstract]
Events and other miscellaneous selling costs	$ 4.6	$ 9.5

Summary of Significant Accoun_5

Summary of Significant Accounting Policies, Inventory (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Inventories [Abstract]
Raw materials	$ 141,823	$ 179,891
Finished goods	185,658	220,040
Total Inventory, net	$ 327,481	$ 399,931

Summary of Significant Accoun_6

Summary of Significant Accounting Policies, Revenue Recognition (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Contract Liabilities - Customer Loyalty Programs [Abstract]
Contract liabilities for customer loyalty programs	$ 17.7		$ 17.7		$ 22
Contract liabilities, increase (decrease) to revenue	$ 0.7	$ (0.7)	$ 4.3	$ (6.3)

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Goodwill [Abstract]
Goodwill	$ 206,432	$ 206,432
Americas [Member]
Goodwill [Abstract]
Goodwill	9,449	9,449
Mainland China [Member]
Goodwill [Abstract]
Goodwill	32,179	32,179
Southeast Asia/Pacific [Member]
Goodwill [Abstract]
Goodwill	18,537	18,537
South Korea [Member]
Goodwill [Abstract]
Goodwill	29,261	29,261
Japan [Member]
Goodwill [Abstract]
Goodwill	16,019	16,019
EMEA [Member]
Goodwill [Abstract]
Goodwill	2,875	2,875
Hong Kong/Taiwan [Member]
Goodwill [Abstract]
Goodwill	6,634	6,634
Manufacturing [Member]
Goodwill [Abstract]
Goodwill	78,875	78,875
Rhyz Other [Member]
Goodwill [Abstract]
Goodwill	$ 12,603	$ 12,603

Debt, 2018 Credit Agreement (De

Debt, 2018 Credit Agreement (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Apr. 18, 2018
2018 Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Consolidated leverage ratio	2.25
2018 Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Consolidated interest coverage ratio	3
2018 Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400	$ 400
Term of loan	5 years
2018 Term Loan Facility [Member] \| First Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
2018 Term Loan Facility [Member] \| Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
2018 Term Loan Facility [Member] \| Third Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
2018 Term Loan Facility [Member] \| Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	7.50%
2018 Term Loan Facility [Member] \| Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	10%
2018 Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 350
Term of loan	5 years

Debt, Credit Agreement (Details

Debt, Credit Agreement (Details) - USD ($) $ in Millions	9 Months Ended
Debt, Credit Agreement (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 14, 2022
Credit Agreement [Member]
Debt [Abstract]
Percentage of capital stock of certain foreign subsidiaries pledged as collateral	65%
Credit Agreement [Member] \| Minimum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.175%
Consolidated interest coverage ratio	3
Credit Agreement [Member] \| Maximum [Member]
Debt [Abstract]
Commitment fee percentage payable on unused portion	0.30%
Consolidated leverage ratio	2.75
Term Loan Facility [Member]
Debt [Abstract]
Original principal amount	$ 400	$ 400
Term of loan	5 years
Term Loan Facility [Member] \| First Year [Member]
Debt [Abstract]
Annual amortization percentage	2.50%
Term Loan Facility [Member] \| Second Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Term Loan Facility [Member] \| Third Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Term Loan Facility [Member] \| Fourth Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Term Loan Facility [Member] \| Fifth Year [Member]
Debt [Abstract]
Annual amortization percentage	5%
Revolving Credit Facility [Member]
Debt [Abstract]
Borrowing capacity		$ 500
Term of loan	5 years

Debt, Debt Facilities (Details)

Debt, Debt Facilities (Details) - USD ($) $ in Thousands		9 Months Ended
Debt, Debt Facilities (Details) - USD ($) $ in Thousands		Sep. 30, 2022	Jun. 14, 2022	Dec. 31, 2021	Apr. 18, 2018
Debt [Abstract]
Term of variable rate		30 days
Current portion of long-term debt		$ 42,500		$ 107,500
2018 Credit Agreement [Member]
Debt [Abstract]
Unamortized debt issuance costs				1,200
2018 Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount		400,000			$ 400,000
Balance	[1],[2]	$ 0		307,500
Interest rate		Variable 30 day: 2.80%
Interest rate		2.80%
Term of variable rate		30 days
Repayment terms		Principal amount was paid in full during June 2022.
Term of loan		5 years
Current portion of long-term debt				37,500
2018 Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance	[1],[2]	$ 0		70,000
Interest rate		Variable 30 day: 2.72%
Interest rate		2.72%
Term of variable rate		30 days
Repayment terms		Principal amount was paid in full during June 2022 and credit line was closed.
Term of loan		5 years
Credit Agreement [Member]
Debt [Abstract]
Unamortized debt issuance costs		$ 2,700
Credit Agreement Term Loan Facility [Member]
Debt [Abstract]
Original principal amount		400,000	$ 400,000
Balance	[1],[2]	$ 397,500		0
Interest rate		Variable 30 day: 4.88%
Interest rate		4.88%
Term of variable rate		30 days
Repayment terms		21% of the principal amount is payable in increasing quarterly installments over a five-year period that began on September 30, 2022, with the remainder payable at the end of the five-year term
Percentage of principal payable in installments		21%
Term of loan		5 years
Current portion of long-term debt		$ 12,500
Credit Agreement Revolving Credit Facility [Member]
Debt [Abstract]
Balance	[1],[2]	$ 30,000		$ 0
Interest rate		Variable 30 day: 4.78%
Interest rate		4.88%
Term of variable rate		30 days
Repayment terms		Revolving line of credit expires June 14, 2027
Term of loan		5 years

[1]As of September 30, 2022 and December 31, 2021, the current portion of the Company’s debt (i.e., becoming due in the next 12 months) included $12.5 million and $37.5 million, respectively, of the balance of its term loan under the Credit Agreement and 2018 Credit Agreement.[2]The carrying value of the debt reflects the amounts stated in the above table, less debt issuance costs of $2.7 million and $1.2 million as of September 30, 2022 and December 31, 2021, respectively, related to the Credit Agreement and 2018 Credit Agreement, which are not reflected in this table.

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Leases (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Weighted average remaining lease term for operating leases	8 years 4 months 24 days		8 years 4 months 24 days
Weighted average remaining lease term for finance leases	3 years		3 years
Weighted average discount rate for operating leases	3.50%		3.50%
Weighted average discount rate for finance leases	3.80%		3.80%
Operating Lease Expense [Abstract]
Operating lease cost	$ 9,479	$ 12,193	$ 30,179	$ 37,408
Variable lease cost	1,572	1,121	4,223	4,145
Short-term lease cost	84	13	181	590
Sublease income	0	(1,352)	0	(5,164)
Finance Lease Expense [Abstract]
Amortization of right-of-use assets	530	594	1,632	1,811
Interest on lease liabilities	53	77	178	248
Total lease expense	11,718	$ 12,646	36,393	39,038
Supplemental Cash Flow Information Related to Leases [Abstract]
Operating cash outflow from operating leases			28,880	40,072
Operating cash outflow from finance leases			170	250
Financing cash outflow from finance leases			1,401	1,409
Right-of-use assets obtained in exchange for operating lease obligations			28,785	19,120
Right-of-use assets obtained in exchange for finance lease obligations			203	$ 59
Maturities of Operating Lease Liabilities [Abstract]
2022	9,453		9,453
2023	26,680		26,680
2024	19,671		19,671
2025	13,775		13,775
2026	8,127		8,127
Thereafter	46,139		46,139
Total	123,845		123,845
Less: Finance charges	16,736		16,736
Total principal liability	107,109		107,109
Maturities of Financing Lease Liabilities [Abstract]
2022	505		505
2023	1,884		1,884
2024	1,688		1,688
2025	1,209		1,209
2026	264		264
Thereafter	4		4
Total	5,554		5,554
Less: Finance charges	319		319
Total principal liability	5,235		5,235
Additional lease liabilities not yet commenced	$ 100		$ 100

Capital Stock, Net Income per S

Capital Stock, Net Income per Share (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stock Options [Member]
Net Income per Share [Abstract]
Anti-dilutive shares excluded from calculation of diluted earnings per share (in shares)	0.5	0.1	0.1	0.1

Capital Stock, Dividends (Detai

Capital Stock, Dividends (Details) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended				9 Months Ended
	Sep. 07, 2022	Jun. 08, 2022	Mar. 09, 2022	Oct. 31, 2022	Aug. 31, 2022	May 31, 2022	Feb. 28, 2022	Sep. 30, 2022	Sep. 30, 2021
Dividends per Share [Abstract]
Payment of cash dividends								$ 57,988	$ 57,336
Dividend Declared 2022-Q1 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2022-02
Dividend payable per share (in dollars per share)							$ 0.385
Payment of cash dividends			$ 19,300
Dividend payable, date paid								Mar. 09, 2022
Dividend payable, date of record								Feb. 28, 2022
Dividend Declared 2022-Q2 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2022-05
Dividend payable per share (in dollars per share)						$ 0.385
Payment of cash dividends		$ 19,400
Dividend payable, date paid								Jun. 08, 2022
Dividend payable, date of record								May 27, 2022
Dividend Declared 2022-Q3 [Member]
Dividends per Share [Abstract]
Dividend payable, date declared								2022-08
Dividend payable per share (in dollars per share)					$ 0.385
Payment of cash dividends	$ 19,300
Dividend payable, date paid								Sep. 07, 2022
Dividend payable, date of record								Aug. 26, 2022
Dividend Declared 2022-Q4 [Member] \| Subsequent Event [Member]
Dividends per Share [Abstract]
Dividend payable, date declared				2022-10
Dividend payable per share (in dollars per share)				$ 0.385
Dividend payable, date paid				Dec. 07, 2022
Dividend payable, date of record				Nov. 25, 2022

Capital Stock, Repurchase of Co

Capital Stock, Repurchase of Common Stock (Details) - USD ($) $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Repurchases of Common Stock [Abstract]
Class A common stock repurchased	$ 40,028	$ 10,005	$ 60,038	$ 70,415
Amount available for repurchases	$ 185,400		$ 185,400
Treasury Stock [Member]
Repurchases of Common Stock [Abstract]
Class A common stock repurchased (in shares)	1	0.2	1.4	1.4
Class A common stock repurchased	$ 40,028	$ 10,005	$ 60,038	$ 70,415

Fair Value and Equity Investm_3

Fair Value and Equity Investments, Fair Value (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Fair Value and Equity Investments [Abstract]
Term of variable rate	30 days
Contingent Consideration [Member]
Changes in Fair Value of Level 3 Contingent Consideration [Roll Forward]
Beginning balance	$ (10,341)	$ (3,125)
Additions from acquisitions	0	(8,702)
Changes in fair value of contingent consideration	1,969	(305)
Ending balance	(8,372)	(12,132)
Fair Value on a Recurring Basis [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	68,552		$ 66,477
Derivative financial instruments asset	21,168		6,590
Life insurance contracts	38,302		49,851
Contingent consideration	(8,372)		(10,341)
Financial assets (liabilities)	119,650		112,577
Fair Value on a Recurring Basis [Member] \| Level 1 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	68,552		66,477
Derivative financial instruments asset	0		0
Life insurance contracts	0		0
Contingent consideration	0		0
Financial assets (liabilities)	68,552		66,477
Fair Value on a Recurring Basis [Member] \| Level 2 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0		0
Derivative financial instruments asset	21,168		6,590
Life insurance contracts	0		0
Contingent consideration	0		0
Financial assets (liabilities)	21,168		6,590
Fair Value on a Recurring Basis [Member] \| Level 3 [Member]
Financial Assets (Liabilities) [Abstract]
Cash equivalents and current investments	0		0
Derivative financial instruments asset	0		0
Life insurance contracts	38,302		49,851
Contingent consideration	(8,372)		(10,341)
Financial assets (liabilities)	29,930		$ 39,510
Life Insurance Contracts [Member]
Changes in Fair Value of Level 3 Marketable Securities [Roll Forward]
Beginning balance	49,851	45,453
Actual return on plan assets	(11,549)	3,172
Purchase and issuances	0	7,016
Sales and settlements	0	(7,016)
Transfers into Level 3	0	0
Ending balance	$ 38,302	$ 48,625

Fair Value and Equity Investm_4

Fair Value and Equity Investments, Equity Investments (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Equity Securities without Readily Determinable Fair Value [Line Items]
Upward fair value adjustments on equity securities		$ 0	$ 18,077
Equity Securities [Member]
Equity Securities without Readily Determinable Fair Value [Line Items]
Carrying amount of equity securities without readily determinable fair values		$ 28,100		$ 28,100
Equity Securities [Member] \| Other Income (Expense), Net [Member]
Equity Securities without Readily Determinable Fair Value [Line Items]
Upward fair value adjustments on equity securities	$ 18,100

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Income Taxes [Abstract]
Provision (benefit) for income taxes	$ (3,574)	$ 18,436	$ 17,052	$ 57,527
Effective tax rate	12.30%	27%	26.40%	26.90%
Net deferred tax assets	$ 22,200		$ 22,200		$ 24,100
Undistributed earnings of non-U.S. subsidiaries					60,000
Incremental taxes if undistributed earnings on non-U.S. subsidiaries were repatriated					$ 6,000
Minimum [Member]
Income Taxes [Abstract]
Increase in unrecognized tax benefits within the next 12 months that is reasonably possible	1,000		$ 1,000
Maximum [Member]
Income Taxes [Abstract]
Statute of limitations related to income tax examinations			10 years
Income Taxes [Abstract]
Increase in unrecognized tax benefits within the next 12 months that is reasonably possible	$ 2,000		$ 2,000

Derivatives and Hedging Activ_3

Derivatives and Hedging Activities, Fair Value of Derivative Instruments on the Balance Sheet (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($) Derivatives	Dec. 31, 2021 USD ($) Derivatives
Derivatives and Hedging Activities [Abstract]
Loss to be reclassified to interest expense during next twelve months	$ 8,200
Number of outstanding derivatives held \| Derivatives	4	4
Notional amount	$ 200,000	$ 200,000
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Prepaid Expenses and Other [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	8,178	557
Interest Rate Swaps [Member] \| Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives and Hedging Activities [Abstract]
Fair value, asset	$ 12,990	$ 6,033

Derivatives and Hedging Activ_4

Derivatives and Hedging Activities, Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Details) - Interest Rate Swaps [Member] - Designated as Hedging Instrument [Member] - Cash Flow Hedges [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income (Expense), Net [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) reclassified from accumulated other comprehensive loss into income	$ 1,040	$ (45)	$ 1,323	$ (110)
Other Comprehensive Income [Member]
Derivatives and Hedging Activities [Abstract]
Gain (loss) recognized in OCI	$ 5,832	$ 32	$ 15,903	$ 3,133

Segment Information, Revenue by

Segment Information, Revenue by Segment (Details) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) Segment	Sep. 30, 2021 USD ($)
Segment Information [Abstract]
Number of reportable segments \| Segment				9
Number of geographic segments \| Segment				7
Number of Rhyz Investments segments \| Segment				2
Revenue by Segment [Abstract]
Revenue		$ 537,805	$ 641,152	$ 1,703,319	$ 2,022,233
Other [Member]
Revenue by Segment [Abstract]
Revenue		496	1,672	2,434	3,497
Operating Segment [Member] \| Nu Skin [Member]
Revenue by Segment [Abstract]
Revenue		495,939	599,392	1,582,352	1,886,310
Operating Segment [Member] \| Americas [Member]
Revenue by Segment [Abstract]
Revenue		131,591	131,482	379,616	403,755
Operating Segment [Member] \| Mainland China [Member]
Revenue by Segment [Abstract]
Revenue		75,151	134,291	286,454	438,066
Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Revenue by Segment [Abstract]
Revenue		83,502	79,081	267,805	246,338
Operating Segment [Member] \| South Korea [Member]
Revenue by Segment [Abstract]
Revenue		67,237	91,989	208,678	261,724
Operating Segment [Member] \| Japan [Member]
Revenue by Segment [Abstract]
Revenue		53,276	65,117	171,019	203,001
Operating Segment [Member] \| EMEA [Member]
Revenue by Segment [Abstract]
Revenue		45,099	55,839	148,938	215,134
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Revenue by Segment [Abstract]
Revenue		39,587	39,921	117,408	114,795
Operating Segment [Member] \| Rhyz Investments [Member]
Revenue by Segment [Abstract]
Revenue		41,866	41,760	120,967	135,923
Operating Segment [Member] \| Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue	[1]	41,328	41,635	119,898	135,760
Operating Segment [Member] \| Rhyz Other [Member]
Revenue by Segment [Abstract]
Revenue		538	125	1,069	163
Intersegment [Member] \| Manufacturing [Member]
Revenue by Segment [Abstract]
Revenue		$ 17,500	$ 27,400	$ 48,900	$ 68,000

[1]The Manufacturing segment had $17.5 million and $27.4 million of intersegment revenue for the three months ended September 30, 2022 and 2021, respectively, and $48.9 million and $68.0 million for the nine months ended September 30, 2022 and 2021, respectively. Intersegment revenue is eliminated in the consolidated financial statements, as well as the reported segment revenue in the table above.

Segment Information, Segment Co

Segment Information, Segment Contribution (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Contribution [Abstract]
Operating income	$ (20,284)	$ 65,384	$ 83,388	$ 213,673
Other income (expense)	(8,680)	2,781	(18,773)	351
Income before provision for income taxes	(28,964)	68,165	64,615	214,024
Operating Segment [Member]
Segment Contribution [Abstract]
Operating income	102,061	138,733	348,992	468,671
Operating Segment [Member] \| Nu Skin [Member]
Segment Contribution [Abstract]
Operating income	102,030	136,333	346,826	454,200
Operating Segment [Member] \| Americas [Member]
Segment Contribution [Abstract]
Operating income	23,016	25,752	78,165	83,495
Operating Segment [Member] \| Mainland China [Member]
Segment Contribution [Abstract]
Operating income	12,933	30,677	54,873	121,596
Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Segment Contribution [Abstract]
Operating income	20,719	19,020	68,492	59,881
Operating Segment [Member] \| South Korea [Member]
Segment Contribution [Abstract]
Operating income	20,455	28,984	63,776	84,401
Operating Segment [Member] \| Japan [Member]
Segment Contribution [Abstract]
Operating income	13,103	16,267	41,867	50,709
Operating Segment [Member] \| EMEA [Member]
Segment Contribution [Abstract]
Operating income	3,379	6,693	13,377	29,270
Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Segment Contribution [Abstract]
Operating income	8,425	8,940	26,276	24,848
Operating Segment [Member] \| Rhyz Investments [Member]
Segment Contribution [Abstract]
Operating income	31	2,400	2,166	14,471
Operating Segment [Member] \| Manufacturing [Member]
Segment Contribution [Abstract]
Operating income	1,755	3,059	6,235	15,649
Operating Segment [Member] \| Rhyz Other [Member]
Segment Contribution [Abstract]
Operating income	(1,724)	(659)	(4,069)	(1,178)
Corporate and Other [Member]
Segment Contribution [Abstract]
Operating income	$ (122,345)	$ (73,349)	$ (265,604)	$ (254,998)

Segment Information, Depreciati

Segment Information, Depreciation and Amortization and Capital Expenditures (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Summarized Financial Information [Abstract]
Depreciation and amortization	$ 18,170	$ 19,933	$ 53,935	$ 57,858
Capital expenditures	25,455	13,535	45,274	50,384
Operating Segments [Member] \| Nu Skin [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	5,392	6,112	15,270	18,731
Capital expenditures	3,809	3,928	12,521	18,124
Operating Segments [Member] \| Americas [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	89	190	480	656
Capital expenditures	23	95	152	294
Operating Segments [Member] \| Mainland China [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,528	3,253	9,088	9,868
Capital expenditures	2,946	3,237	9,066	15,170
Operating Segments [Member] \| Southeast Asia/Pacific [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	382	359	1,144	1,096
Capital expenditures	19	92	143	1,015
Operating Segments [Member] \| South Korea [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	377	805	1,137	2,768
Capital expenditures	35	0	613	508
Operating Segments [Member] \| Japan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	148	220	670	699
Capital expenditures	16	3	200	94
Operating Segments [Member] \| EMEA [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	125	281	599	850
Capital expenditures	183	391	961	821
Operating Segments [Member] \| Hong Kong/Taiwan [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	743	1,004	2,152	2,794
Capital expenditures	587	110	1,386	222
Operating Segments [Member] \| Rhyz Investments [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,753	3,661	11,549	9,631
Capital expenditures	1,923	2,604	4,353	11,604
Operating Segments [Member] \| Manufacturing [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	3,161	3,069	9,773	8,644
Capital expenditures	1,923	2,604	4,353	11,604
Operating Segments [Member] \| Rhyz Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	592	592	1,776	987
Capital expenditures	0	0	0	0
Corporate and Other [Member]
Summarized Financial Information [Abstract]
Depreciation and amortization	9,025	10,160	27,116	29,496
Capital expenditures	$ 19,723	$ 7,003	$ 28,400	$ 20,656

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended
Acquisitions (Details) - USD ($) $ in Thousands	Apr. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Acquisitions [Abstract]
Purchase price, net of cash acquired		$ 0	$ 18,963
Fair Value of Assets Acquired [Abstract]
Goodwill		$ 206,432		$ 206,432
Mavely [Member]
Acquisitions [Abstract]
Percentage interest acquired	100%
Purchase price, net of cash acquired	$ 16,800
Cash acquired	400
Accrued liability	900
Incremental contingent consideration	24,000
Contingent consideration	8,700
Gross purchase price	29,400
Fair Value of Assets Acquired [Abstract]
Intangible assets	16,400
Cash	400
Accounts receivable	100
Deferred tax liability	3,500
Goodwill	12,600
Mavely [Member] \| Customer Relationships [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,000
Useful life		4 years
Mavely [Member] \| Technology [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	11,300
Useful life		8 years
Mavely [Member] \| Trademarks [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	2,800
Mavely [Member] \| Tradenames [Member]
Fair Value of Assets Acquired [Abstract]
Useful life		8 years
Mavely [Member] \| Other Intangibles [Member]
Fair Value of Assets Acquired [Abstract]
Intangible assets	$ 300
Useful life		3 years

Restructuring, Exit Grow Tech S

Restructuring, Exit Grow Tech Segment (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring [Abstract]
Non-cash impairment charges	$ 30,124				$ 0	$ 30,124	$ 0
Cash payments	300	$ 8,000	$ 11,600
Ending restructuring accrual	$ 0	$ 300	$ 8,300			$ 0
Exit Grow Tech Segment [Member]
Restructuring [Abstract]
Non-cash impairment charges				$ 38,500
Impairment of goodwill				9,200
Impairment of intangible assets				9,000
Impairment of fixed assets				13,700
Inventory write-off				6,600
Cash charges associated with restructuring				20,000
Employee severance				6,500
Other related restructuring charges				13,500
Exit Grow Tech Segment [Member] \| Accrued Expenses [Member]
Restructuring [Abstract]
Liability related to cash charges				$ 20,000

Restructuring, Focus Resources

Restructuring, Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability (Details) - USD ($) $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Restructuring [Abstract]
Cash payments	$ 300	$ 8,000	$ 11,600
Ending restructuring accrual	0	$ 300	$ 8,300		$ 0
Restructuring expense	30,124			$ 0	30,124	$ 0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member]
Restructuring [Abstract]
Severance charges	17,200
Lease termination cost	2,100
Other associated restructuring charges	900
Impairment of fixed assets	8,200
Impairment of intangible assets	1,700
Cash payments	7,900
Ending restructuring accrual	12,300				12,300
Restructuring expense	30,124
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Minimum [Member]
Restructuring [Abstract]
Estimated restructuring costs	35,000				35,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Maximum [Member]
Restructuring [Abstract]
Estimated restructuring costs	45,000				45,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Nu Skin [Member]
Restructuring [Abstract]
Restructuring expense	15,565
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Americas [Member]
Restructuring [Abstract]
Restructuring expense	1,723
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Mainland China [Member]
Restructuring [Abstract]
Restructuring expense	11,484
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Southeast Asia/Pacific [Member]
Restructuring [Abstract]
Restructuring expense	663
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| South Korea [Member]
Restructuring [Abstract]
Restructuring expense	54
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Japan [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| EMEA [Member]
Restructuring [Abstract]
Restructuring expense	894
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Hong Kong/Taiwan [Member]
Restructuring [Abstract]
Restructuring expense	747
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Rhyz Investments [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Manufacturing [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Operating Segment [Member] \| Rhyz Other [Member]
Restructuring [Abstract]
Restructuring expense	0
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Corporate and Other [Member]
Restructuring [Abstract]
Restructuring expense	14,559
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Severance and Lease Termination [Member] \| Minimum [Member]
Restructuring [Abstract]
Estimated restructuring costs	30,000				30,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Severance and Lease Termination [Member] \| Maximum [Member]
Restructuring [Abstract]
Estimated restructuring costs	35,000				35,000
Focus Resources on Strategic Priorities and Optimize Future Growth and Profitability [Member] \| Impairment of Fixed Assets and Other Intangibles Related to Footprint Optimization [Member]
Restructuring [Abstract]
Estimated restructuring costs	$ 9,900				$ 9,900